[350 Pages Report] Newly released data from the fertility supplements market analyzed by FMI estimates that the fertility supplements market enjoyed year-on-year (YoY) growth of 8.3% in 2021 to total 243,820 MT. The fertility supplements market is expected to witness a prominent growth rate of a CAGR of 8.3% to reach the value of US$ 4,382 Mn in 2031.
| Attribute | Details |
|---|---|
| Market Size Value in 2020 | US$ 1,817.6 Million |
| Market Forecast Value in 2031 | US$ 4,382 Million |
| Global Growth Rate | ~8.3% |
| Forecast Period | 2021 to 2031 |
Fertility supplements have been found to aid in increasing fertility rates, healthy pregnancy, and boosting delivery by promoting ovulation and improving hormonal profiles. Men and women of childbearing age can both experience infertility to avoid which, consumers are taking preventative healthcare measures like fertility supplements, therefore, boosting the market.
According to research by the American Society for Reproductive Medicine, the male partner is responsible for infertility in roughly 40% of infertile couples, and approximately 80%–90% of these couples are treated with pharmaceuticals including fertility supplements products like herbal fertility supplements, natural fertility supplements, vegan fertility supplements, etc. As a result, boosting the fertility supplements market.
Fertility supplements business research performed by FMI covers crucial findings such as the latest developments by key producers and projected production capacity, the current pricing of various levels of the supply chain, and price optimization plan across the value chain, as well as an economic evaluation of fertility supplements manufacturing.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Market Statistics | Details |
|---|---|
| H1,2021 (A) | 8.2% |
| H1,2022 Projected (P) | 8.3% |
| H1,2022 Outlook (O) | 9.1% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 83 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 91.3 ↑ |
FMI provides an evaluation and comparison of the market growth rates and future development possibilities on a half-yearly basis for the global market. Under the subjective influence of macro and industry factors, some demographic and innovation factors have a significant influence on the market.
There have been a number of recent changes in this market, including:
The Fertility Supplements Market has grown by 8.2% globally in the first half of 2021. However, this growth is not uniformly distributed across all geographical areas, with the developing markets registering greater growth rates of 9.1%. Thus, there will be a 91.3 BPS point difference between the predicted and projected growth in H1 2022.
The primary causes of this variation in growth rate are ascribed to the market's slow or rapid uptake during the first half of the projected period as a result of improving end-user demand in important economies and their expanding populations.
China and India in particular are both experiencing a growth in their consumption patterns, which is driving up demand for Fertility Supplements Market. Numerous other market segments should also perform well and have bright development potential in the second half of the projected period.
Despite these promising developments, the business is still expected to face significant obstacles, such as shifting customer preferences, strict trade restrictions, and a lack of security in the supply of raw materials and other manufacturing inputs.
As per FMI – market study and competitive intellect provider, in past few years, the inclusive market value for fertility supplements grew at a compound annual growth rate of around 6.4% in 2021.
Market participants are striving to strategically develop distribution warehouses for fertility supplements in order to support time- and cost-effective logistic operations. Rising infertility rates worldwide are another key factor for the rising demand for fertility supplements. 10% of women are facing infertility issues worldwide, according to WHO. The concern for the issue has caused a rise in the demand for the product.
According to FMI, the US fertility supplements market is expected to grow at a CAGR of 8.9% by 2031 due to the fact that today's lifestyle causes more harm to the average person than ever before. According to the American Society for Reproductive Medicine, many men and women of reproductive age in the United States smoke cigarettes. Cigarette smoking has a negative impact on a person's general health and well-being. It also has a negative impact on their fertility. The fertility supplements market is expected to grow as more people become aware of the current problem and learn about potential remedies.
Germany has a market share of 20.9% in the European fertility supplements market, in 2021 (According to FMI) with a growth rate of 8.6% over the assessment period.
In Germany, the rising frequency of obesity and the expanding number of diabetic patients are driving up demand for fertility supplements. Menstrual disorders and anovulation are more common in overweight women. Women who are overweight or obese are at a higher risk of having a miscarriage.
These women have a higher risk of sub fecundity and infertility, as well as higher risks of conception, miscarriage, and pregnancy problems, therefore, the country has a higher consumption of the product as a preventative measure.
India has a market share of 42.1% in the South Asian fertility supplements market, in 2021 (According to FMI) with a growth rate of 10.9% over the assessment period.
Infertility has been one of the most common health difficulties that many young couples have been dealing with in recent years in the country. Sedentary lives with little physical activity, growing stress levels, and unpredictable sleep patterns are only a few of the factors that contribute to infertility, pushing some to resort to in vitro fertilization. Infertility affects between 10% to 14% of the Indian population, according to The Indian Society of Assisted Reproduction, with greater rates in metropolitan areas, where one out of every six couples is affected.
According to the most recent assessment by FMI, the fertility supplements market size of Brazil in 2021 is US$ 77.0 Mn and is expected to expand at a CAGR of 7.1% by 2031.
Preterm birth has been on the rise all throughout the world, especially in Brazil. Because of the greater rates of morbidity and mortality, as well as the long-term health consequences of preterm birth, posing a substantial public health threat. This augments the sales of fertility supplements in the Brazilian market as a preventative measure.
According to FMI, the sales of fertility supplements in China are assessed at around 51.6% of the overall East Asian market in 2021, with a growth rate of 7.6%.
The growth has been recorded due to the rising awareness of the benefits provided by fertility supplements for to be mothers. The heightening knowledge about, supplementing may also be beneficial when attempting to conceive, which is also boosting the market in the country.
Principal Consultant
The natural fertility supplements segment of the market holds a significant percentage, which is expected to rise at a CAGR of 9.0% by 2031.
In 2021, the natural segment of the fertility supplements market accounted for US$ 1,057.3 Mn and is expected to expand at a market share of 56.7% by 2031 due to the introduction of innovative products and technical advances like nutrition trackers, fitness trackers, etc., in the health and wellness industry. In the near future, increasing the use of plant-derived products for a healthy lifestyle and lowering the risk of side effects is predicted to drive demand even higher.
According to FMI, the women population is anticipated to witness a significant consumption of fertility supplements and experience a lucrative growth rate of CAGR 8.2% over the forecast period.
Immune system factors, varicocele, hypogonadism, systemic disease, urogenital infection, sexual factors, are some of the prominent factors leading to fertility problems in women, therefore, promoting the fertility supplements market amongst this end user category.
The capsules category accounted for a significant market share of 43.5% in the fertility supplements industry in 2021. These solutions allow for innovative ingredient combinations, give protection from sensitive ingredients, prevent gastrointestinal irritation, and assure the delivery of oil and fat-soluble nutrients. This element is expected to contribute to the boost of the capsule fertility supplements market.
The players are expanding in number due to the rising demand for fertility supplements in various parts of the world. The companies are working on research and development to understand the market in-depth and innovate the product to match the competition like organic, non-GMO, etc.
A prenatal nutrition and education company, needed, has raised $5.8 million through seed funding to expand its products offerings to include sleep, stress, and reproductive difficulties. The money will also be used to fund new clinical studies on nutrition during pregnancy by the Los Angeles-based company, therefore, promoting the fertility supplements market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Market Size Value in 2020 | US$ 1,817.6 Million |
| Market Forecast Value in 2031 | US$ 4,382 Million |
| Global Growth Rate | ~8.3% |
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | MT for Volume and US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe East Asia, South Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Rest of Latin America, Germany, Italy, France, UK, Spain, BENELUX, Nordic, Russia, Poland, Rest of Europe, India, Thailand, Indonesia, Malaysia, Singapore, Rest of South Asia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, South Africa, Rest of MEA |
| Key Market Segments Covered | Type, Form, End User, Sales Channel, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
By Type :
By Form :
By End User :
By Sales Channel :
Region :
The fertility supplements market size is worth more than US$ 1,968.4 Mn in 2021.
Fertility supplements consumption is expected to grow at a CAGR of around 8.3% during the period 2021-2031.
In terms of revenue fertility supplements grew at a CAGR of around 6.4% during 2016-2020
Fertility supplements are gaining traction as a preventative health care measure against rising infertility rates, and advanced technologies, are the latest trends of fertility supplements being observed in the market.
Market companies are choosing to aim at research and development, consolidation of distribution channels in emerging countries, new product introductions to stay a noticeable player in the global market.
The top 20 producers of fertility supplements hold around 45-50% of the market share.
The US, Australia, GCC Countries, China, and Germany are the major countries driving demand for fertility supplements.
Europe holds around 25.6% of the total fertility supplements revenue share in 2021.
The US fertility supplements market is projected to grow at a CAGR of around 8.9% over the next ten years.
The report presents a detailed cost analysis of fertility supplements based on form i.e. natural, synthetic, and blend.
1. Market Overview 1.1. Market Coverage / Taxonomy 1.2. Market Definition / Scope / Limitations 2. The Massive Impact of the Crisis 2.1. Global Market Forecast Scenario Comparison of Annual Growth Rates for short Term (2021-2025) and Long Term (2026-2031) 2.1.1. Optimistic Scenario 2.1.1.1. China 2.1.1.2. US 2.1.1.3. India 2.1.1.4. Euro Zone 2.1.1.5. Asia Pacific 2.1.1.6. Rest of the World 2.1.2. Likely Scenario 2.1.2.1. China 2.1.2.2. US 2.1.2.3. India 2.1.2.4. Euro Zone 2.1.2.5. Asia Pacific 2.1.2.6. Rest of the World 2.1.3. Pessimistic Scenario 2.1.3.1. China 2.1.3.2. US 2.1.3.3. India 2.1.3.4. Euro Zone 2.1.3.5. Asia Pacific 2.1.3.6. Rest of the World 2.2. Key Factors Impacting the Market Note: Market Assessment shall be Provided for Likely Scenario 3. Market Background 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Type Launches 3.6. Type Claims & Nutritional Information Scan by Buyers 3.7. Scan by Buyers 3.8. Macro-Economic Factors 3.9. Forecast Factors - Relevance & Impact 3.10. Consumers Survey Analysis 4. Key Regulations 4.1. Packaging & Labelling Regulations 4.2. Certifications and Certifying Agency Overview 4.3. Import/Export Policies 5. Value Chain Analysis 5.1. Operating margins at each node of the supply chain 5.2. List of Active Market Participants 5.2.1. Raw Material Suppliers 5.2.2. Type Manufacturers 5.2.3. Key Brands 6. Production and Trade Outlook-Fertility Supplements 6.1. Total Production Vs Consumption by Country 6.2. Key Importing Countries by Volume/Value 6.3. Key Exporting Countries by Volume/Value 6.4. Natural Market Overview 6.4.1. Global Natural Supplements Production Overview 6.4.2. Countries with largest Natural Supplements Consumption 6.5. Per Capita Consumption Analysis 6.5.1. Per Capita Consumption Analysis By Country 6.5.2. Per Capita Expenditure on Fertility Supplements 7. Global Market Demand Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020 7.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031 7.3. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis (US$/Metric Tons) By Form 8.2. Pricing Break-up By category 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Type, 2016 - 2020 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Type, 2021-2031 10.3.1. Capsules 10.3.2. Soft gels 10.3.3. Powders 10.3.4. Liquids 10.3.5. Others 10.4. Market Attractiveness Analysis By Type 11. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Form 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Form, 2016 - 2020 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Form, 2021-2031 11.3.1. Natural 11.3.2. Synthetic 11.3.3. Blend 11.4. Market Attractiveness Analysis By Form 12. Global Market Analysis 2016-2020 and Forecast 2021-2031, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2016 - 2020 12.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End User, 2021-2031 12.3.1. Men 12.3.2. Women 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Sales Channel 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) and Volume Analysis By Sales Channel, 2016 - 2020 13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Sales Channel, 2021-2031 13.3.1. Over the Counter 13.3.2. Prescribed 13.4. Market Attractiveness Analysis By Sales Channel 14. Global Market Analysis 2016-2020 and Forecast 2021-2031, By Region 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016 - 2020 14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. East Asia 14.3.5. South Asia 14.3.6. Oceania 14.3.7. Middle East and Africa (MEA) 14.4. Market Attractiveness Analysis By Region 15. North America Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 15.4.1. By Country 15.4.1.1. U.S. 15.4.1.2. Canada 15.4.2. By Type 15.4.3. By Form 15.4.4. End User 15.4.5. Sales Channel 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Type 15.5.3. By Form 15.5.4. End User 15.5.5. Sales Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Latin America Market Analysis 2016-2020 and Forecast 2021-2031 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 16.4.1. By Country 16.4.1.1. Brazil 16.4.1.2. Mexico 16.4.1.3. Argentina 16.4.1.4. Chile 16.4.1.5. Rest of Latin America 16.4.2. By Type 16.4.3. By Form 16.4.4. End User 16.4.5. Sales Channel 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Type 16.5.3. By Form 16.5.4. End User 16.5.5. Sales Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Europe Market Analysis 2016-2020 and Forecast 2021-2031 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 17.4.1. By Country 17.4.1.1. EU-4 17.4.1.2. U.K. 17.4.1.3. BENELUX 17.4.1.4. Nordic 17.4.1.5. Russia 17.4.1.6. Poland 17.4.1.7. Rest of Europe 17.4.2. By Type 17.4.3. By Form 17.4.4. End User 17.4.5. Sales Channel 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Type 17.5.3. By Form 17.5.4. End User 17.5.5. Sales Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2016-2020 and Forecast 2021-2031 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Type 18.4.3. By Form 18.4.4. End User 18.4.5. Sales Channel 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Type 18.5.3. By Form 18.5.4. End User 18.5.5. Sales Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. South Asia Market Analysis 2016-2020 and Forecast 2021-2031 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 19.4.1. By Country 19.4.1.1. India 19.4.1.2. Thailand 19.4.1.3. Singapore 19.4.1.4. Malaysia 19.4.1.5. Rest of South Asia 19.4.2. By Type 19.4.3. By Form 19.4.4. End User 19.4.5. Sales Channel 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Type 19.5.3. By Form 19.5.4. End User 19.5.5. Sales Channel 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Oceania Market Analysis 2016-2020 and Forecast 2021-2031 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 20.4.1. By Country 20.4.1.1. Australia 20.4.1.2. New Zealand 20.4.2. By Type 20.4.3. By Form 20.4.4. End User 20.4.5. Sales Channel 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Type 20.5.3. By Form 20.5.4. End User 20.5.5. Sales Channel 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2031 21.1. Introduction 21.2. Pricing Analysis 21.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 21.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 21.4.1. By Country 21.4.1.1. GCC Countries 21.4.1.2. Turkey 21.4.1.3. Northern Africa 21.4.1.4. South Africa 21.4.1.5. Rest of Middle East and Africa 21.4.2. By Type 21.4.3. By Form 21.4.4. End User 21.4.5. Sales Channel 21.5. Market Attractiveness Analysis 21.5.1. By Country 21.5.2. By Type 21.5.3. By Form 21.5.4. End User 21.5.5. Sales Channel 21.6. Market Trends 21.7. Key Market Participants - Intensity Mapping 21.8. Drivers and Restraints - Impact Analysis 22. Key Countries Bulk Ingredients Market Analysis 2016–2020 and Forecast 2021–2031 22.1. U.S. 22.1.1. Introduction 22.1.2. Pricing Analysis (2016, 2021, 2031) 22.1.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.1.3.1. By Type 22.1.3.2. By Form 22.1.3.3. By End User 22.1.3.4. By Sales Channel 22.2. Canada 22.2.1. Introduction 22.2.2. Pricing Analysis (2016, 2021, 2031) 22.2.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.2.3.1. By Type 22.2.3.2. By Form 22.2.3.3. By End User 22.2.3.4. By Sales Channel 22.3. Brazil 22.3.1. Introduction 22.3.2. Pricing Analysis (2016, 2021, 2031) 22.3.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.3.3.1. By Type 22.3.3.2. By Form 22.3.3.3. By End User 22.3.3.4. By Sales Channel 22.4. Mexico 22.4.1. Introduction 22.4.2. Pricing Analysis (2016, 2021, 2031) 22.4.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.4.3.1. By Type 22.4.3.2. By Form 22.4.3.3. By End User 22.4.3.4. By Sales Channel 22.5. Argentina 22.5.1. Introduction 22.5.2. Pricing Analysis (2016, 2021, 2031) 22.5.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.5.3.1. By Type 22.5.3.2. By Form 22.5.3.3. By End User 22.5.3.4. By Sales Channel 22.6. Peru 22.6.1. Introduction 22.6.2. Pricing Analysis (2016, 2021, 2031) 22.6.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.6.3.1. By Type 22.6.3.2. By Form 22.6.3.3. By End User 22.6.3.4. By Sales Channel 22.7. Chile 22.7.1. Introduction 22.7.2. Pricing Analysis (2016, 2021, 2031) 22.7.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.7.3.1. By Type 22.7.3.2. By Form 22.7.3.3. By End User 22.7.3.4. By Sales Channel 22.8. Germany 22.8.1. Introduction 22.8.2. Pricing Analysis (2016, 2021, 2031) 22.8.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.8.3.1. By Type 22.8.3.2. By Form 22.8.3.3. By End User 22.8.3.4. By Sales Channel 22.9. Italy 22.9.1. Introduction 22.9.2. Pricing Analysis (2016, 2021, 2031) 22.9.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.9.3.1. By Type 22.9.3.2. By Form 22.9.3.3. By End User 22.9.3.4. By Sales Channel 22.10. France 22.10.1. Introduction 22.10.2. Pricing Analysis (2016, 2021, 2031) 22.10.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.10.3.1. By Type 22.10.3.2. By Form 22.10.3.3. By End User 22.10.3.4. By Sales Channel 22.11. U.K. 22.11.1. Introduction 22.11.2. Pricing Analysis (2016, 2021, 2031) 22.11.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.11.3.1. By Type 22.11.3.2. By Form 22.11.3.3. By End User 22.11.3.4. By Sales Channel 22.12. Spain 22.12.1. Introduction 22.12.2. Pricing Analysis (2016, 2021, 2031) 22.12.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.12.3.1. By Type 22.12.3.2. By Form 22.12.3.3. By End User 22.12.3.4. By Sales Channel 22.13. BENELUX 22.13.1. Introduction 22.13.2. Pricing Analysis (2016, 2021, 2031) 22.13.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.13.3.1. By Type 22.13.3.2. By Form 22.13.3.3. By End User 22.13.3.4. By Sales Channel 22.14. Russia 22.14.1. Introduction 22.14.2. Pricing Analysis (2016, 2021, 2031) 22.14.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.14.3.1. By Type 22.14.3.2. By Form 22.14.3.3. By End User 22.14.3.4. By Sales Channel 22.15. India 22.15.1. Introduction 22.15.2. Pricing Analysis (2016, 2021, 2031) 22.15.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.15.3.1. By Type 22.15.3.2. By Form 22.15.3.3. By End User 22.15.3.4. By Sales Channel 22.16. Thailand 22.16.1. Introduction 22.16.2. Pricing Analysis (2016, 2021, 2031) 22.16.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.16.3.1. By Type 22.16.3.2. By Form 22.16.3.3. By End User 22.16.3.4. By Sales Channel 22.17. Indonesia 22.17.1. Introduction 22.17.2. Pricing Analysis (2016, 2021, 2031) 22.17.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.17.3.1. By Type 22.17.3.2. By Form 22.17.3.3. By End User 22.17.3.4. By Sales Channel 22.18. Malaysia 22.18.1. Introduction 22.18.2. Pricing Analysis (2016, 2021, 2031) 22.18.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.18.3.1. By Type 22.18.3.2. By Form 22.18.3.3. By End User 22.18.3.4. By Sales Channel 22.19. China 22.19.1. Introduction 22.19.2. Pricing Analysis (2016, 2021, 2031) 22.19.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.19.3.1. By Type 22.19.3.2. By Form 22.19.3.3. By End User 22.19.3.4. By Sales Channel 22.20. Japan 22.20.1. Introduction 22.20.2. Pricing Analysis (2016, 2021, 2031) 22.20.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.20.3.1. By Type 22.20.3.2. By Form 22.20.3.3. By End User 22.20.3.4. By Sales Channel 22.21. South Korea 22.21.1. Introduction 22.21.2. Pricing Analysis (2016, 2021, 2031) 22.21.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.21.3.1. By Type 22.21.3.2. By Form 22.21.3.3. By End User 22.21.3.4. By Sales Channel 22.22. Australia 22.22.1. Introduction 22.22.2. Pricing Analysis (2016, 2021, 2031) 22.22.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.22.3.1. By Type 22.22.3.2. By Form 22.22.3.3. By End User 22.22.3.4. By Sales Channel 22.23. New Zealand 22.23.1. Introduction 22.23.2. Pricing Analysis (2016, 2021, 2031) 22.23.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.23.3.1. By Type 22.23.3.2. By Form 22.23.3.3. By End User 22.23.3.4. By Sales Channel 22.24. GCC Countries 22.24.1. Introduction 22.24.2. Pricing Analysis (2016, 2021, 2031) 22.24.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.24.3.1. By Type 22.24.3.2. By Form 22.24.3.3. By End User 22.24.3.4. By Sales Channel 22.25. Central Africa 22.25.1. Introduction 22.25.2. Pricing Analysis (2016, 2021, 2031) 22.25.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.25.3.1. By Type 22.25.3.2. By Form 22.25.3.3. By End User 22.25.3.4. By Sales Channel 22.26. North Africa 22.26.1. Introduction 22.26.2. Pricing Analysis (2016, 2021, 2031) 22.26.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.26.3.1. By Type 22.26.3.2. By Form 22.26.3.3. By End User 22.26.3.4. By Sales Channel 22.27. South Africa 22.27.1. Introduction 22.27.2. Pricing Analysis (2016, 2021, 2031) 22.27.3. Market Value and Volume Analysis 2016–2020 and Forecast 2021–2031 22.27.3.1. By Type 22.27.3.2. By Form 22.27.3.3. By End User 22.27.3.4. By Sales Channel 23. Market Structure Analysis 23.1. Market Analysis by Tier of Companies 23.2. Company Share Analysis of Top Players 23.2.1. Company share by Region 23.2.2. Company Share By Type 23.3. Market Presence Analysis 23.3.1. By Regional footprint of Players 23.3.2. Product foot print by Players 23.3.3. Channel Foot Print by Players 24. Competition Analysis 24.1. Competition Dashboard 24.2. Competition Deep Dive (Tentative List) 24.2.1. Fertility Nutraceuticals LLC 24.2.1.1. Overview 24.2.1.2. Type Portfolio 24.2.1.3. Profitability by Market Segments (Type/Channel/Region) 24.2.1.4. Sales Footprint 24.2.1.5. Strategy Overview 24.2.1.5.1. Marketing Strategy 24.2.1.5.2. Type Strategy 24.2.2. Exeltis USA, Inc. 24.2.2.1. Overview 24.2.2.2. Type Portfolio 24.2.2.3. Profitability by Market Segments (Type/Channel/Region) 24.2.2.4. Sales Footprint 24.2.2.5. Strategy Overview 24.2.2.5.1. Marketing Strategy 24.2.2.5.2. Type Strategy 24.2.3. TTK HealthCare Ltd. 24.2.3.1. Overview 24.2.3.2. Type Portfolio 24.2.3.3. Profitability by Market Segments (Type/Channel/Region) 24.2.3.4. Sales Footprint 24.2.3.5. Strategy Overview 24.2.3.5.1. Marketing Strategy 24.2.3.5.2. Type Strategy 24.2.4. PregPrep LLC 24.2.4.1. Overview 24.2.4.2. Type Portfolio 24.2.4.3. Profitability by Market Segments (Type/Channel/Region) 24.2.4.4. Sales Footprint 24.2.4.5. Strategy Overview 24.2.4.5.1. Marketing Strategy 24.2.4.5.2. Type Strategy 24.2.5. Orthomol pharmazeutische Vertriebs GmbH 24.2.5.1. Overview 24.2.5.2. Type Portfolio 24.2.5.3. Profitability by Market Segments (Type/Channel/Region) 24.2.5.4. Sales Footprint 24.2.5.5. Strategy Overview 24.2.5.5.1. Marketing Strategy 24.2.5.5.2. Type Strategy 24.2.6. Active Bio Life Science GmbH 24.2.6.1. Overview 24.2.6.2. Type Portfolio 24.2.6.3. Profitability by Market Segments (Type/Channel/Region) 24.2.6.4. Sales Footprint 24.2.6.5. Strategy Overview 24.2.6.5.1. Marketing Strategy 24.2.6.5.2. Type Strategy 24.2.7. Fairhaven Health, LLC 24.2.7.1. Overview 24.2.7.2. Type Portfolio 24.2.7.3. Profitability by Market Segments (Type/Channel/Region) 24.2.7.4. Sales Footprint 24.2.7.5. Strategy Overview 24.2.7.5.1. Marketing Strategy 24.2.7.5.2. Type Strategy 24.2.8. Lenus Pharma GesmbH 24.2.8.1. Overview 24.2.8.2. Type Portfolio 24.2.8.3. Profitability by Market Segments (Type/Channel/Region) 24.2.8.4. Sales Footprint 24.2.8.5. Strategy Overview 24.2.8.5.1. Marketing Strategy 24.2.8.5.2. Type Strategy 24.2.9. ZenithNutrition 24.2.9.1. Overview 24.2.9.2. Type Portfolio 24.2.9.3. Profitability by Market Segments (Type/Channel/Region) 24.2.9.4. Sales Footprint 24.2.9.5. Strategy Overview 24.2.9.5.1. Marketing Strategy 24.2.9.5.2. Type Strategy 24.2.10. INVO Bioscience 24.2.10.1. Overview 24.2.10.2. Type Portfolio 24.2.10.3. Profitability by Market Segments (Type/Channel/Region) 24.2.10.4. Sales Footprint 24.2.10.5. Strategy Overview 24.2.10.5.1. Marketing Strategy 24.2.10.5.2. Type Strategy 24.2.11. Other Players (On Additional Requests) 24.2.11.1. Overview 24.2.11.2. Type Portfolio 24.2.11.3. Profitability by Market Segments (Type/Channel/Region) 24.2.11.4. Sales Footprint 24.2.11.5. Strategy Overview 24.2.11.5.1. Marketing Strategy 24.2.11.5.2. Type Strategy 25. Assumptions and Acronyms Used 26. Research Methodology
Explore Food and Beverage Insights
View Reports
Fertility Supplements Market
